HTB homepage • Conference reports • Articles by subject • Subscribe 9 January 2002 Contents Conference reports 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 16-19 December 2001 Low dose pegylated interferon is ineffective in treating HIV/HCV co-infected patients Phenotypic resistance to ddI is less frequent than resistance to ZDV, 3TC and abacavir Impact of Kaletra on amprenavir plasma concentrations in HIV treatment-experienced patients Immune reconstitution more difficult with low baseline CD4+ T cell counts HIV-1 may revert to less pathogenic strain a few days after starting HAART Change from CCR5 to CXCR4 phenotype may affect immunologic responses ddI EC (Videx) study confirms and clarifies dosing on an empty stomach Swatch study: should we be cycling drugs? New HIV drugs, resistance, pharmacogenomics Antiretroviral therapy Immunopathogenesis of HIV infection Basic science and immunology New findings explain T-cell loss in HIV infection Other news Voluntary suspension of Kava-kava sales following safety concerns The Chapman Clinic: musculoskeletal treatment for patients with HIV On the web Additional reports from ICAAC 2001 Double scourge: tuberculosis and HIV coinfection The road to eradication: is HAART hard enough? HTB homepage • Conference reports • Articles by subject • Subscribe
